INTRODUCTION: To improve the synthesis and quality control of carbon-11 labeled radiopharmaceuticals, we report the fully automated loop syntheses of [¹¹C]raclopride and [¹¹C]DASB using ethanol as the only organic solvent for synthesis module cleaning, carbon-11 methylation, HPLC purification, and reformulation. METHODS: Ethanolic loop chemistry is fully automated using a GE TRACERLab FX(C-Pro) synthesis module, and is readily adaptable to any other carbon-11 synthesis apparatus. Precursors (1 mg) were dissolved in ethanol (100 μL) and loaded into the HPLC loop. [¹¹C]MeOTf was passed through the HPLC loop and then the labeled products were purified by semi-preparative HPLC and reformulated into ethanolic saline. RESULTS: Both [¹¹C]raclopride (3.7% RCY; >95% RCP; SA=20831 Ci/mmol; n=64) and [¹¹C]DASB, both with (3.0% RCY; >95% RCP; SA=15152Ci/mmol; n=9) and without (3.0% RCY; >95% RCP; SA=10931 Ci/mmol; n=3) sodium ascorbate, have been successfully prepared using the described methodology. Doses are suitable for human use and the described methods are now employed for routine clinical production of both radiopharmaceuticals at the University of Michigan. CONCLUSIONS: Ethanolic loop chemistry is a powerful technique for preparing [¹¹C]raclopride and [¹¹C]DASB, and we are in the process of adapting it for other carbon-11 radiopharmaceuticals prepared in our laboratories ([¹¹C]PMP, [¹¹C]PBR28 etc.).
INTRODUCTION: To improve the synthesis and quality control of carbon-11 labeled radiopharmaceuticals, we report the fully automated loop syntheses of [¹¹C]raclopride and [¹¹C]DASB using ethanol as the only organic solvent for synthesis module cleaning, carbon-11 methylation, HPLC purification, and reformulation. METHODS: Ethanolic loop chemistry is fully automated using a GE TRACERLab FX(C-Pro) synthesis module, and is readily adaptable to any other carbon-11 synthesis apparatus. Precursors (1 mg) were dissolved in ethanol (100 μL) and loaded into the HPLC loop. [¹¹C]MeOTf was passed through the HPLC loop and then the labeled products were purified by semi-preparative HPLC and reformulated into ethanolic saline. RESULTS: Both [¹¹C]raclopride (3.7% RCY; >95% RCP; SA=20831 Ci/mmol; n=64) and [¹¹C]DASB, both with (3.0% RCY; >95% RCP; SA=15152Ci/mmol; n=9) and without (3.0% RCY; >95% RCP; SA=10931 Ci/mmol; n=3) sodium ascorbate, have been successfully prepared using the described methodology. Doses are suitable for human use and the described methods are now employed for routine clinical production of both radiopharmaceuticals at the University of Michigan. CONCLUSIONS: Ethanolic loop chemistry is a powerful technique for preparing [¹¹C]raclopride and [¹¹C]DASB, and we are in the process of adapting it for other carbon-11 radiopharmaceuticals prepared in our laboratories ([¹¹C]PMP, [¹¹C]PBR28 etc.).
Authors: Xia Shao; Raphaël Hoareau; Brian G Hockley; Louis J M Tluczek; Bradford D Henderson; Henry C Padgett; Peter J H Scott Journal: J Labelled Comp Radiopharm Date: 2011-05-30 Impact factor: 1.921
Authors: Peter J H Scott; Brian G Hockley; Hank F Kung; Rajesh Manchanda; Wei Zhang; Michael R Kilbourn Journal: Appl Radiat Isot Date: 2008-09-07 Impact factor: 1.513
Authors: Katrin C Probst; David Izquierdo; Joseph L E Bird; Laurent Brichard; Dominic Franck; John R Davies; Tim D Fryer; Hugh K Richards; John C Clark; Anthony P Davenport; Peter L Weissberg; Elizabeth A Warburton Journal: Nucl Med Biol Date: 2007-05 Impact factor: 2.408
Authors: Emmanuelle Briard; Sami S Zoghbi; Masao Imaizumi; Jonathan P Gourley; H Umesha Shetty; Jinsoo Hong; Vanessa Cropley; Masahiro Fujita; Robert B Innis; Victor W Pike Journal: J Med Chem Date: 2007-12-08 Impact factor: 7.446
Authors: Nachwa Jarkas; Ronald J Voll; Larry Williams; John R Votaw; Mike Owens; Mark M Goodman Journal: J Med Chem Date: 2007-12-18 Impact factor: 7.446
Authors: Masahiro Ono; Alan Wilson; Jose Nobrega; David Westaway; Paul Verhoeff; Zhi-Ping Zhuang; Mei-Ping Kung; Hank F Kung Journal: Nucl Med Biol Date: 2003-08 Impact factor: 2.408
Authors: Allen F Brooks; Isaac M Jackson; Xia Shao; George W Kropog; Phillip Sherman; Carole A Quesada; Peter J H Scott Journal: Medchemcomm Date: 2015-06-01 Impact factor: 3.597
Authors: Maxim E Sergeev; Federica Morgia; Mark Lazari; Christopher Wang; R Michael van Dam Journal: J Am Chem Soc Date: 2015-04-22 Impact factor: 15.419
Authors: Jinsoo Hong; Sanjay Telu; Yi Zhang; William H Miller; H Umesha Shetty; Cheryl L Morse; Victor W Pike Journal: Nat Protoc Date: 2021-08-06 Impact factor: 13.491
Authors: Clayton A Whitmore; Mariam I Boules; William J Behof; Justin R Haynes; Dmitry Koktysh; Adam J Rosenberg; Mohammed N Tantawy; Wellington Pham Journal: Molecules Date: 2021-04-10 Impact factor: 4.411